Editors' Pick T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial. Karussis D, Shor H, Yachnin J, Lanxner N, Amiel M, Baruch K, Keren-Zur Y, Haviv O, Filippi M, Petrou P, et al. PLoS One. 2012; 7(12):e50478. Epub 2012 Dec 14. PMID: 23272061. Abstract CommentRecommendBookmarkWatch